Format

Send to

Choose Destination
J Neuropathol Exp Neurol. 2015 Sep;74(9):867-72. doi: 10.1097/NEN.0000000000000226.

BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.

Author information

1
From the Bristol Genetics Laboratory, Pathology Sciences, Southmead Hospital, Bristol (CF, AP, CW, MG, MW); Brain Tumour Research Group, Institute of Clinical Neurosciences, Southmead Hospital (HPE, AS, CP, HRH, HW, KMK); Department of Paediatric Oncology, Bristol Royal Hospital for Children (SL); and Applied Statistics Group, University of the West of England (PW), Bristol, UK; and Department of Neuropathology, Institute of Pathology, University of Heidelberg and CCU Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Abstract

Pilocytic astrocytomas (PAs) are increasingly tested for KIAA1549-BRAF fusions. We used reverse transcription polymerase chain reaction for the 3 most common KIAA1549-BRAF fusions, together with BRAF V600E and histone H3.3 K27M analyses to identify relationships of these molecular characteristics with clinical features in a cohort of 32 PA patients. In this group, the overall BRAF fusion detection rate was 24 (75%). Ten (42%) of the 24 had the 16-9 fusion, 8 (33%) had only the 15-9 fusion, and 1 (4%) of the patients had only the 16-11 fusion. In the PAs with only the 15-9 fusion, 1 PA was in the cerebellum and 7 were centered in the midline outside of the cerebellum, that is, in the hypothalamus (n = 4), optic pathways (n = 2), and brainstem (n = 1). Tumors within the cerebellum were negatively associated with fusion 15-9. Seven (22%) of the 32 patients had tumor-related deaths and 25 of the patients (78%) were alive between 2 and 14 years after initial biopsy. Age, sex, tumor location, 16-9 fusion, and 15-9 fusion were not associated with overall survival. Thus, in this small cohort, 15-9 KIAA1549-BRAF fusion was associated with midline PAs located outside of the cerebellum; these tumors, which are generally difficult to resect, are prone to recurrence.

PMID:
26222501
PMCID:
PMC4554227
DOI:
10.1097/NEN.0000000000000226
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center